Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms

NCT05124691 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

1001

Enrollment

OTHER

Sponsor class

Stopped Primary Endpoint met

Conditions

Helminthes; Infestation, Intestinal

Interventions

COMBINATION_PRODUCT: Albendazole and Ivermectin fixed dose coformulation
DRUG: Albendazole

Sponsor

Barcelona Institute for Global Health

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]